1-[(1-METHYL-1H-TETRAZOL-5-YL)-THIOACETYL]-3-(2-THIENYL)-5-(4-CHLOROPHENYL)-2-PYRAZOLINE
Compound with spectra: 1 NMR
![1-[(1-METHYL-1H-TETRAZOL-5-YL)-THIOACETYL]-3-(2-THIENYL)-5-(4-CHLOROPHENYL)-2-PYRAZOLINE](/api/compound/2wE1xrV8B1v.png?ph=true&h=300&w=458 "1-[(1-METHYL-1H-TETRAZOL-5-YL)-THIOACETYL]-3-(2-THIENYL)-5-(4-CHLOROPHENYL)-2-PYRAZOLINE")
| SpectraBase Compound ID | 2wE1xrV8B1v |
|---|---|
| InChI | InChI=1S/C17H15ClN6OS2/c1-23-17(19-21-22-23)27-10-16(25)24-14(11-4-6-12(18)7-5-11)9-13(20-24)15-3-2-8-26-15/h2-8,14H,9-10H2,1H3 |
| InChIKey | JGYSSXMCMPELHO-UHFFFAOYSA-N |
| Mol Weight | 418.92 g/mol |
| Molecular Formula | C17H15ClN6OS2 |
| Exact Mass | 418.043729 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1-[(4-METHYL-4H-1,2,4-TRIAZOL-3-YL)-THIOACETYL]-3-(2-THIENYL)-5-(4-CHLOROPHENYL)-2-PYRAZOLINE
1-[(5-METHYL-1,3,4-THIADIAZOL-2-YL)-THIOACETYL]-3-(2-THIENYL)-5-(4-CHLOROPHENYL)-2-PYRAZOLINE
5-[3,5-di(2-thienyl)-4,5-dihydro-1H-pyrazol-1-yl]-5-oxopentanoic acid
1H-pyrazole, 1-acetyl-5-(5-chloro-2-furanyl)-4,5-dihydro-3-(2-thienyl)-
1H-pyrazole-1-butanoic acid, 5-(2-furanyl)-4,5-dihydro-gamma-oxo-3-(2-thienyl)-
1H-pyrazole, 1-acetyl-4,5-dihydro-5-(5-methyl-2-furanyl)-3-(2-thienyl)-
(2E)-4-[5-(2-furyl)-3-(2-thienyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-2-butenoic acid
5-[5-(4-chlorophenyl)-3-(3,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-5-oxopentanoic acid
morpholine, 4-[3-[4,5-dihydro-5-(3-nitrophenyl)-3-phenyl-1H-pyrazol-1-yl]-3-oxopropyl]-
1-N-Allylthiocarbamoyl-3,5-di-(2-thienyl)-2-pyrazoline
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents | Molecules | 2015 |